-
Ferrostatin-1 and Oxidative Lipid Damage
2026-09-16
Skouta and colleagues established ferrostatin-1 as a selective inhibitor of ferroptosis that protects cells by suppressing oxidative lipid damage rather than by broadly eliminating reactive oxygen species. By extending the analysis across Huntington’s disease, periventricular leukomalacia, and kidney dysfunction models, the study connected membrane lipid peroxidation with diverse disease-associated cell-death phenotypes and used a mechanistic model to guide improved ferrostatin analogues.
-
Pertussis Toxin as a Translational Immune Probe
2026-09-15
Pertussis toxin is more than a conventional immunology reagent: it is a controlled cAMP-linked perturbation tool that can help researchers dissect dendritic-cell responses, contextualize microglial biology, and design stronger translational studies around the TREM2–ERK/p38 axis.
-
LRPPRC–Dasatinib Dual OXPHOS Disruption
2026-09-15
A 2026 study identified dasatinib as a synergistic partner for LRPPRC inhibition through complementary suppression of nuclear- and mitochondrial genome-encoded OXPHOS genes. The findings provide a mechanistic rationale for combination strategies in LRPPRC-high tumors while remaining limited to preclinical cancer-cell models.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-09-14
Oh et al. developed a scalable human induced pluripotent stem cell-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. The model combines neuronal functional validation with virological and chromatin-based criteria, providing a more human-relevant platform for studying latent infection than conventional nonhuman systems alone.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-14
The reference study identifies reduced endogenous hydrogen sulfide production as a component of palmitate-associated cardiac lipotoxicity and links this deficit to endoplasmic reticulum stress. Its combined patient, animal, and AC16-cell experiments suggest that restoring H2S signaling can reduce lipid accumulation, apoptosis, and myocardial injury, while also defining practical boundaries for translating the findings into live-cell assays.
-
Kanamycin Sulfate for Reproducible Microbiology
2026-09-13
Kanamycin Sulfate provides a practical selection pressure for plasmid-bearing bacteria while also serving as a controlled variable in antibiotic resistance research. This guide connects preparation, selection, troubleshooting, and microbiota-aware assay design with insights from recent C. difficile toxin research.
-
DOPE Workflows for Nucleic Acid Delivery
2026-09-12
DOPE is a membrane-fusion helper that can improve endosomal escape in cationic liposomes and LNPs, while also serving as a defined phosphatidylethanolamine perturbation in fungal lipid-peroxidation assays. This guide connects formulation design, rice blast mechanistic experiments, and practical troubleshooting without treating delivery performance as proof of a ferroptosis mechanism.
-
LAG-3–TCR Proximity Suppresses T Cells and Autoimmunity
2026-09-12
The 2025 Cell study shows that LAG-3-mediated suppression depends on spatial proximity to the T cell receptor (TCR), rather than on MHC class II binding or CD4 proximity alone. Its mechanistic and therapeutic experiments connect LAG-3–TCR proximity to CD3ε/Lck disruption and establish a TCR/LAG-3 bispecific antibody as a strategy for suppressing pathogenic T cells in autoimmune disease models.
-
Tankyrase Inhibition in Hepatocellular Carcinoma
2026-09-11
Jia et al. showed that selective tankyrase inhibition restrains hepatocellular carcinoma cell growth while suppressing YAP/TEAD activity and increasing the inhibitory angiomotin-like proteins AMOTL1 and AMOTL2. The study is notable because it connects tankyrase activity to Hippo-pathway regulation, extending mechanistic analysis beyond the better-known Wnt/β-catenin axis.
-
GANT61: Practical GLI Inhibitor Workflows
2026-09-11
GANT61 provides a tractable way to test whether GLI1/2 activity drives proliferation, transcriptional remodeling, or treatment resistance. This guide connects concentration-controlled cell assays with tumor–immune experiments inspired by recent findings on GLI2, WNT signaling, prostaglandins, and immunotherapy resistance.
-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-09-10
The reference preprint shows that selected p38α kinase inhibitors can do more than block catalysis: they can also accelerate WIP1-mediated dephosphorylation by stabilizing a phosphatase-accessible activation-loop conformation. This structure-guided concept provides a mechanistic framework for interpreting inhibitor potency and selectivity in inflammatory signaling research.
-
AP-2α–MGMT Control of TMZ Resistance in Recurrent GBM
2026-09-10
The reference study identifies AP-2α as a transcriptional suppressor of MGMT in recurrent glioblastoma and shows that restoring AP-2α activity improves temozolomide-associated DNA damage. Its combination of promoter-binding evidence, resistant-cell models, and an intracranial relapse model connects transcriptional regulation with therapeutic response and suggests a framework for studying MGMT-dependent TMZ resistance.
-
BI 2536: A Mechanistic Guide to PLK1 Checkpoints
2026-09-09
BI 2536 is a selective PLK1 inhibitor that connects mitotic checkpoint biochemistry with measurable G2/M arrest and apoptosis. This guide shows how to design assays that distinguish direct checkpoint effects from downstream loss of tumor-cell proliferation.
-
NVP-BGJ398 Phosphate: FGFR Assay Workflows
2026-09-09
NVP-BGJ398 phosphate supports mechanism-focused FGFR1–3 inhibition studies in cancer models and extends into FGFR3-driven skeletal disease research. This guide translates published findings into practical cell, signaling, tissue, and troubleshooting workflows.
-
Protease Inhibitor Cocktail for OXPHOS Workflows
2026-09-08
Protect intact LRPPRC and OXPHOS proteins during cell, tissue, Western blot, and co-immunoprecipitation workflows. This EDTA-free, DMSO-based formulation supports metal-sensitive assay chemistry while providing broad-spectrum control of proteolysis.